stockrowEmergent Biosolutions Inc. (EBS) vs Siga Technologies Inc. (SIGA)
- Emergent Biosolutions Inc. EBS 5.92 +0.34%
- Siga Technologies Inc. SIGA 2.97 −5.71%
Emergent Biosolutions Inc. and Siga Technologies Inc. are both Drug Manufacturers Specialty & Generic companies. Emergent Biosolutions Inc. is the larger, with a market value of $300.8M against $213.4M — 1.4× the size. Emergent Biosolutions Inc. grew revenue faster over the last twelve months: −17.7% against −70.1%. Siga Technologies Inc. has the higher net margin (−5.19% vs −40.2%) and the higher return on invested capital (−14.6% vs −17.5%). Across the 19 metrics below, Siga Technologies Inc. leads on 12 and Emergent Biosolutions Inc. on 7.
Valuation
Profitability
| Metric | EBS | SIGA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 48.42% | 54.35% | 53.51% |
| Operating margin | (27.70%) | (20.76%) | 0.00% |
| Net margin | (40.16%) | (5.19%) | (2.45%) |
| Free cash flow margin | 29.89% | (37.58%) | 0.00% |
| Return on equity | (58.21%) | (1.49%) | (0.80%) |
| Return on assets | (21.23%) | (1.36%) | (1.67%) |
| Return on invested capital | (17.45%) | (14.59%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack